Not applicableStudy completedNCT03729661What this trial is testingExploratory Study on Therapy for Breath Hold in RadiotherapyWho this might be right forLung CancerBreast Cancer Maastricht Radiation Oncology 20
Not applicableStudy completedNCT03856372What this trial is testingHypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast CancerWho this might be right forBreast Cancer Fudan University 1,494
Early research (Phase 1)Looking for participantsNCT05005403What this trial is testingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanWho this might be right forNon-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more AbbVie
Not applicableStudy completedNCT01508273What this trial is testingLifestyle Intervention for High Risk Cancer SurvivorsWho this might be right forBreast Cancer M.D. Anderson Cancer Center 1,150
Testing effectiveness (Phase 2)WithdrawnNCT03384095What this trial is testingTrial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated ArthralgiasWho this might be right forBreast Neoplasm FemaleArthralgia Erin Newton
Early research (Phase 1)Active Not RecruitingNCT03589339What this trial is testingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyWho this might be right forRadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more Nanobiotix 145
Testing effectiveness (Phase 2)UnknownNCT05556200What this trial is testingA Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILsWho this might be right forBreast CancerTriple-Negative Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 58
Testing effectiveness (Phase 2)Study completedNCT00002509What this trial is testingHigh-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast CancerWho this might be right forBreast Cancer Temple University
Not applicableEnded earlyNCT03560102What this trial is testingEfficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast CancerWho this might be right forBreast Cancer, Invasive Ductal Kantonsspital Winterthur KSW 1
Not applicableStudy completedNCT04378751What this trial is testingPromoting Genetic Counseling Among African American Women With a Family History of Breast CancerWho this might be right forHigh Risk for Breast Cancer University of Illinois at Chicago 80
Testing effectiveness (Phase 2)UnknownNCT00080756What this trial is testingDeslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseaseWho this might be right forbrca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer City of Hope Medical Center 11
Not applicableNot Yet RecruitingNCT07705100What this trial is testingClinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).Who this might be right forBreast Cancer Detection University of Arizona 50
Not applicableStudy completedNCT05797129What this trial is testingCEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective StudyWho this might be right forBreast Cancer Kaohsiung Veterans General Hospital. 351
Not applicableStudy completedNCT03471741What this trial is testingIntensity Modulated Radiotherapy With Concomitant Boost in Breast CancerWho this might be right forBreast CancerRadiation Toxicity IRCCS Azienda Ospedaliero-Universitaria di Bologna 451
Not applicableUnknownNCT03617341What this trial is testingBrain Monitoring for High Risk of Brain Metastases in Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer With HER2 PositiveTriple Negative Breast Cancer Yonsei University 200
Large-scale testing (Phase 3)Study completedNCT01547741What this trial is testingDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc 4,242
Testing effectiveness (Phase 2)UnknownNCT04247633What this trial is testingHigh Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)Who this might be right forBreast Cancer Samsung Medical Center 578
Not applicableStudy completedNCT00026949What this trial is testingStudy of Etoposide in Breast Cancer PatientsWho this might be right forBreast Cancer National Cancer Institute (NCI) 33
Not applicableNot Yet RecruitingNCT07187674What this trial is testingThe Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and PaclitaxelWho this might be right forTriple Negative Breast Cancer (TNBC) Harbin Medical University 20
Large-scale testing (Phase 3)UnknownNCT00944424What this trial is testingPhase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast caWho this might be right forBreast Cancer King Faisal Specialist Hospital & Research Center 260